Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality

Recent advances in the molecular design and applications of proteolysis targeting chimera-based multi-specific antiviral modality

Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strat...

Full description

Bibliographic Details
Main Authors:	Yang Zhou, Shujing Xu, Nerea López-Carrobles, Dang Ding, Xinyong Liu, Luis Menéndez-Arias, Peng Zhan
Format:	Article
Language:	English
Published:	Compuscript Ltd 2023-08-01
Series:	Acta Materia Medica
Subjects:	viruses antiviral drugs targeted protein degradation protac multi-specific drugs
Online Access:	https://www.scienceopen.com/hosted-document?doi=10.15212/AMM-2023-0019

Similar Items

Proteolysis-Targeting Chimeras (PROTACs) in Cancer Therapy: Present and Future
by: Rui Li, et al.
Published: (2022-12-01)

From classic medicinal chemistry to state‐of‐the‐art interdisciplinary medicine: Recent advances in proteolysis‐targeting chimeras technology
by: Xuyang Zhao, et al.
Published: (2023-04-01)

Recent Advances in PROTAC-Based Antiviral Strategies
by: Haleema Ahmad, et al.
Published: (2023-01-01)

Proteolysis-targeting chimeras (PROTACs) in cancer therapy
by: Xinyi Li, et al.
Published: (2022-04-01)

Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy
by: Yujeong Moon, et al.
Published: (2023-01-01)

Photopharmacology of Proteolysis-Targeting Chimeras: A New Frontier for Drug Discovery
by: Shenxin Zeng, et al.
Published: (2021-03-01)

Proteolysis targeting chimeras (PROTACs) in cancer therapy
by: Alberto Ocaña, et al.
Published: (2020-09-01)

Computer aided drug design in the development of proteolysis targeting chimeras
by: Tin M. Tunjic, et al.
Published: (2023-01-01)

A Mechanistic Pharmacodynamic Modeling Framework for the Assessment and Optimization of Proteolysis Targeting Chimeras (PROTACs)
by: Robin Thomas Ulrich Haid, et al.
Published: (2023-01-01)

Design, Synthesis and Biological Evaluation of α-Synuclein Proteolysis-Targeting Chimeras
by: Tianzhi Wen, et al.
Published: (2023-05-01)

Antiviral PROTACs: Opportunity borne with challenge
by: Jinsen Liang, et al.
Published: (2023-06-01)

Potential application of proteolysis targeting chimera (PROTAC) modification technology in natural products for their targeted protein degradation
by: Guliang Yang, et al.
Published: (2022-03-01)

Recent advances of PROTACs technology in neurodegenerative diseases
by: Chao Wang, et al.
Published: (2023-09-01)

A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery
by: Janarthanan Venkatesan, et al.
Published: (2022-11-01)

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
by: Yonghan He, et al.
Published: (2020-07-01)

The Potential of Proteolytic Chimeras as Pharmacological Tools and Therapeutic Agents
by: Bernat Coll-Martínez, et al.
Published: (2020-12-01)

Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges
by: Chao Wang, et al.
Published: (2022-12-01)

MDM2-Based Proteolysis-Targeting Chimeras (PROTACs): An Innovative Drug Strategy for Cancer Treatment
by: André T. S. Vicente, et al.
Published: (2022-09-01)

Inducing the Degradation of Disease-Related Proteins Using Heterobifunctional Molecules
by: Alexandré Delport, et al.
Published: (2019-09-01)

Design, Synthesis, and Biological Evaluation of Proteolysis Targeting Chimeras (PROTACs) for the Dual Degradation of IGF-1R and Src
by: Sudhakar Manda, et al.
Published: (2020-04-01)

Proteolysis-Targeting Chimera (PROTAC) Delivery into the Brain across the Blood-Brain Barrier
by: Toshihiko Tashima
Published: (2023-06-01)

Recent Advances in Optically Controlled PROTAC
by: Muzi Ouyang, et al.
Published: (2023-11-01)

Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2,3-dioxygenase 1
by: Mingxing Hu, et al.
Published: (2020-10-01)

Discovery of oseltamivir-based novel PROTACs as degraders targeting neuraminidase to combat H1N1 influenza virus
by: Zhichao Xu, et al.
Published: (2022-06-01)

Recent Advances in PROTACs for Drug Targeted Protein Research
by: Tingting Yao, et al.
Published: (2022-09-01)

Degradation of neurodegenerative disease-associated TDP-43 aggregates and oligomers via a proteolysis-targeting chimera
by: Yu-Ling Tseng, et al.
Published: (2023-04-01)

Newly Emerging Strategies in Antiviral Drug Discovery: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Anniversary
by: Shujing Xu, et al.
Published: (2022-01-01)

Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system
by: Ke Ma, et al.
Published: (2021-01-01)

Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma Activity
by: Salma Darwish, et al.
Published: (2022-07-01)

Recent Advances on Targeting Proteases for Antiviral Development
by: Pedro Henrique Oliveira Borges, et al.
Published: (2024-02-01)

Central Nervous System Targeted Protein Degraders
by: Bedwyr ab Ion Thomas, et al.
Published: (2023-07-01)

Design, Synthesis, and Antitumor Activity Evaluation of Proteolysis-Targeting Chimeras as Degraders of Extracellular Signal-Regulated Kinases 1/2
by: Pengming Pan, et al.
Published: (2023-11-01)

Protein-Targeted Degradation Agents Based on Natural Products
by: Yan Li, et al.
Published: (2022-12-01)

Linkers as Game-changers in PROTAC Technology: Emphasizing General Trends in PROTAC Pharmacokinetics for their Rational Design
by: Carlotta Cecchini, et al.
Published: (2022-04-01)

Targeting CDK9 in Cancer: An Integrated Approach of Combining In Silico Screening with Experimental Validation for Novel Degraders
by: Mahesh Koirala, et al.
Published: (2024-02-01)

Emerging Strategies in Proteolysis-Targeting Chimeras (PROTACs): Highlights from 2022
by: Rekha Tamatam, et al.
Published: (2023-03-01)

News from DMCCB – Targeted Protein Degradation
by: Georg Jaeschke
Published: (2018-12-01)

Proteolysis-targeting chimeras and their implications in breast cancer
by: Angeles C. Tecalco-Cruz, et al.
Published: (2021-12-01)

A proteolysis-targeting chimera molecule selectively degrades ENL and inhibits malignant gene expression and tumor growth
by: Xin Li, et al.
Published: (2022-04-01)

Reversible Covalent PROTACs: Novel and Efficient Targeted Degradation Strategy
by: Minghua Yuan, et al.
Published: (2021-07-01)